Key Financial Inc
CLRB icon

Key Financial Inc’s Cellectar Biosciences CLRB Stock Holding History

Key Financial Inc’s Portfolio CLRB Stock Details CLRB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$6 Buy
+3
New +$7 ﹤0.01% 1309

Other funds holding CLRB

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
TD Waterhouse Canada
TD Waterhouse Canada Toronto, Ontario, Canada $38.4B AUM 30.28% 1-Year Est. Return
SBI Securities
SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return
Danske Bank
Danske Bank Copenhagen K, Denmark $50.1B AUM 35.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Key Financial Inc's CLRB Position: Q3 2026 in Review

Key Financial Inc opened a new position in Cellectar Biosciences (CLRB) in Q3 2026: 3 shares worth $6. The stake represents ﹤0.01% of the portfolio and ranks #1309 among its holdings.

8 funds tracked by Wall St. Rank hold CLRB as of Q3 2026.

  • Key Financial Inc held 3 shares of Cellectar Biosciences worth $6 as of Q3 2026.
  • Cellectar Biosciences was a new Key Financial Inc position in Q3 2026.
  • Cellectar Biosciences made up ﹤0.01% of Key Financial Inc's portfolio in Q3 2026, its #1309 holding.
  • 8 funds tracked by Wall St. Rank held Cellectar Biosciences as of Q3 2026.

Based on Key Financial Inc's 13F filing for Q3 2026, filed 2 Nov 2026.